Dawnrays Pharmaceutical (Holdings) Management
Management criteria checks 2/4
Dawnrays Pharmaceutical (Holdings)'s CEO is Weixian Wu, appointed in Feb 2022, has a tenure of 2.08 years. total yearly compensation is CN¥3.09M, comprised of 58.1% salary and 41.9% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth HK$2.34M. The average tenure of the management team and the board of directors is 17.5 years and 15.9 years respectively.
Key information
Weixian Wu
Chief executive officer
CN¥3.1m
Total compensation
CEO salary percentage | 58.1% |
CEO tenure | 2.1yrs |
CEO ownership | 0.1% |
Management average tenure | 17.5yrs |
Board average tenure | 15.9yrs |
Recent management updates
Recent updates
Dawnrays Pharmaceutical (Holdings) (HKG:2348) Is Due To Pay A Dividend Of CN¥0.065
Mar 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.015
Aug 30Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Shareholders Will Receive A Bigger Dividend Than Last Year
May 26Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.073
Apr 04Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 19Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals
Sep 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015
Sep 12Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015
Aug 29Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend
Feb 28Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?
Feb 07Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares
Jan 14Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Dec 22What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?
Dec 09Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend
Nov 23CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | CN¥326m |
Sep 30 2023 | n/a | n/a | CN¥384m |
Jun 30 2023 | n/a | n/a | CN¥442m |
Mar 31 2023 | n/a | n/a | CN¥400m |
Dec 31 2022 | CN¥3m | CN¥2m | CN¥358m |
Compensation vs Market: Weixian's total compensation ($USD426.96K) is above average for companies of similar size in the Hong Kong market ($USD319.87K).
Compensation vs Earnings: Insufficient data to compare Weixian's compensation with company performance.
CEO
Weixian Wu (54 yo)
2.1yrs
Tenure
CN¥3,086,000
Compensation
Mr. Weixian Wu serves as Chief Executive Officer of Dawnrays Pharmaceutical (Holdings) Limited since February 16, 2022. He joined Nanjing PharmaRays Science and Technology Co., Ltd., a non-wholly owned sub...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & Executive Chairman | 21.4yrs | CN¥999.00k | 7.16% CN¥ 125.6m | |
Chief Executive Officer | 2.1yrs | CN¥3.09m | 0.13% CN¥ 2.3m | |
Co-Founder & Executive Director | 29.2yrs | CN¥638.00k | 0.13% CN¥ 2.2m | |
Chief Financial Officer | 5.9yrs | no data | no data | |
Company Secretary | no data | no data | no data |
17.5yrs
Average Tenure
59yo
Average Age
Experienced Management: 2348's management team is seasoned and experienced (17.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder & Executive Chairman | 21.4yrs | CN¥999.00k | 7.16% CN¥ 125.6m | |
Co-Founder & Executive Director | 21.4yrs | CN¥638.00k | 0.13% CN¥ 2.2m | |
Independent Non-Executive Director | 8.8yrs | CN¥309.00k | no data | |
Non-Executive Director | 18.3yrs | CN¥258.00k | no data | |
Independent Non-Executive Director | 13.4yrs | CN¥309.00k | no data | |
Independent Non-Executive Director | 5.8yrs | CN¥309.00k | no data |
15.9yrs
Average Tenure
59.5yo
Average Age
Experienced Board: 2348's board of directors are seasoned and experienced ( 15.9 years average tenure).